Sendero Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
2,014
+1,282
+175% +$1.31M 0.24% 71
2026
Q1
$673K Sell
732
-53
-7% -$53.7K 0.07% 139
2025
Q4
$843K Buy
+785
New +$751K 0.09% 121

Other funds holding LLY

Sendero Wealth Management's LLY Position: Q2 2026 in Review

Sendero Wealth Management increased its Eli Lilly (LLY) stake by 175% in Q2 2026, buying an estimated $1.31M and bringing the position to 2,014 shares worth $2.42M. The position accounts for 0.24% of the portfolio, ranked #71.

Sendero Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sendero Wealth Management held 2,014 shares of Eli Lilly worth $2.42M as of Q2 2026.
  • Sendero Wealth Management bought 1,282 Eli Lilly shares in Q2 2026, an estimated $1.31M.
  • Eli Lilly made up 0.24% of Sendero Wealth Management's portfolio in Q2 2026, its #71 holding.
  • Sendero Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sendero Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.